Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphomaEgil Støre Blix(University Hospital of North Norway), Arne Kolstad(Oslo University Hospital)BMC CancerOctober 16, 201210.1186/1471-2407-12-478Cited by 32SaveCiteExport RISWatch citationsRelated PapersTisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial|Nature Medicine|2021|523Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases|Blood|2011|178138 | PHASE 2 ELARA TRIAL 4‐YEAR UPDATE: CLINICAL OUTCOMES OF TISAGENLECLEUCEL IN PATIENTS (PTS) WITH HIGH‐RISK RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)|Hematological Oncology|2025|1